Compass Pathways is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are studying investigational psilocybin treatment in treatment …

Compass Pathways is the largest company in the psychedelic medicine industry [5] and, in 2020, was the first psychedelic medicine company to be listed on the NASDAQ. [1]

Oct 31, 2024 · About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health.

Find the latest COMPASS Pathways plc (CMPS) stock quote, history, news and other vital information to help you with your stock trading and investing.

Nov 5, 2025 · We are Compass Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those …

Our vision is a world of mental wellbeing | We are Compass Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health.

Visit this page to learn more about Compass Pathways, our values and our commitment to mental health care innovations and mental wellbeing.

4 days ago · COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS - Get Free Report) shares hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $7.15 …

Compass clinical trial programmes in treatment-resistant depression, post-traumatic stress disorder, and anorexia nervosa 11

23 hours ago · COMPASS Pathways plc (NASDAQ:CMPS) is among the Best Get Rich Fast Stocks to Buy Right Now. As of December 24, COMPASS Pathways plc (NASDAQ:CMPS) has a ‘Buy’ or …